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Diethyhexyl phthalate (DEHP) is an environmental pollutant used universally as a 
plasticizer in polyvinyl consumer products.  Exposure to DEHP increases risk of 
adverse pregnancy outcomes in humans, including decreased gestation length, 
preterm birth, low birth weight, and early pregnancy loss.   Moreover, mono-
ethylhexyl phthalate (MEHP), the active metabolite of DEHP increases oxidative 
stress and inflammatory responses in vitro.  Because oxidative stress and 
inflammatory responses are linked to the pathogenesis of preterm birth, we 
investigated MEHP stimulated oxidative stress and inflammatory responses in 
human gestational cells and tissues as mechanisms by which MEHP exposure 
may contribute to preterm birth.  To identify whether MEHP exposure induces  
oxidative stress responses in the gestational compartment, we treated human 
placental cells (HTR-8/SVneo) with MEHP and measured reactive oxygen 
species (ROS) generation using the dichlorofluorescein (DCF) assay, oxidized 
thymine (oT) with mass-spectrometry, redox-sensitive gene expression with qRT-
PCR, and activation of caspase 3/7 using a luminescence assay.  We found that 
MEHP increased ROS generation, oxidative DNA damage, and apoptosis, and 




mRNA expression of prostaglandin-endoperoxide synthase 2 (PTGS2), the gene 
for COX-2, an enzyme important for prostaglandin synthesis.  To assess whether 
MEHP may stimulate inflammatory responses in the gestational compartment, 
we treated human primary placental macrophages, primary decidual 
macrophages, gestational membrane explants, and HTR-8 cells with MEHP and 
measured prostaglandin and cytokine release using enzyme-linked 
immunosorbent assays (ELISA) and PTGS2 mRNA expression using qRT-PCR.  
Our results demonstrate that MEHP treatment significantly increased total 
prostaglandin, PGF2!, and PGE2 release in human primary placental 
macrophage Hofbauer cells, and induced PTGS2 mRNA expression in the HTR-
8 human trophoblast cell line.   MEHP treatment showed no effect on pro-
inflammatory cytokine release.  The results from the present study are consistent 
with the hypothesis that MEHP stimulates oxidative stress and prostaglandin 
synthesis in gestational tissues and cells.  The findings from the current study 
warrant future epidemiological studies of oxidative stress and prostaglandin 
synthesis as mechanisms by which MEHP may contribute to preterm birth and 







DEHP is an abundant environmental pollutant 
Di-2-ethylhexyl phthalate (DEHP) (Figure 1.1A), a phthalic acid ester, is a 
ubiquitous environmental pollutant used primarily in plastic products to impart 
flexibility.  DEHP can be found in a wide variety of consumer products ranging 
from medical tubing and blood storage bags to plastic food containers, shower 
curtains, children’s toys, clothing, automobile and furniture upholstery.  Because 
DEHP is not covalently bound to plastic, it is particularly susceptible to leeching 
into the environment. Consequently, DEHP has been found in at least 733 of the 
1,613 Environmental Protection Agency National Priorities List sites and in 2005, 
the EPA listed DEHP as an ATSDR priority chemical.  The ubiquitous nature of 
DEHP has resulted in wide-spread exposure in the US population.  A recent 
study conducted by the National Health and Nutrition Examination Survey 
(NHANES) found measureable levels of monoethylhexyl phthalate (MEHP) 
(Figure 1.1B), the active monoester metabolite of DEHP, in nearly every urine 
sample analyzed.  Because DEHP is rapidly metabolized to its active monoester 
metabolites and excreted in the urine, the latter finding suggests that exposure to 
DEHP is essentially a daily occurrence.   
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DEHP is a reproductive toxicant 
Exposure to DEHP is associated with a number of negative reproductive 
health outcomes in both humans and animals, including abnormal Leydig cell 
aggregation, disruption of steroidogenesis and cholesterol uptake in rat testes 
(Ge, Chen et al. 2007), and  decreased anogenital distance—an index of 
prenatal androgen status-- in human male infants (Marsee, Woodruff et al. 2006).   
In female rats, DEHP exposure reduces serum levels of progesterone and 
estradiol, and suppresses ovulation (Davis, Maronpot et al. 1994). DEHP is 
associated with adverse pregnancy outcomes in humans including decreased 
gestation length, preterm birth, low birth weight, and early pregnancy loss (Latini, 
De Felice et al. 2003).  Furthermore, measureable levels of MEHP are found in 
human cord blood, amniotic fluid, and placenta (Mose, Mortensen et al. 2007; 
Wittassek, Angerer et al. 2009; Lin, Ku et al. 2011). Though the latter studies 
suggest that the gestational compartment may be a target of MEHP toxicity, 
further studies are needed to elucidate the mechanisms underlying adverse 
pregnancy outcomes.   
Preterm birth is a significant health problem 
Preterm birth, defined as live birth occurring before 37 completed weeks of 
gestation, affects 21 million infants worldwide and half a million, or 1 in 8, infants 
per year in the U.S.  Furthermore, preterm birth accounts for nearly one-third of 
all neonatal mortalities (Callaghan, MacDorman et al. 2006).  Among preterm 
infants that survive, many develop long-term health complications later in life, 
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including blindness, deafness, cerebral palsy, and low IQ.  Consequently, 
medical costs due to preterm birth represent a significant economic burden, 
costing the U.S. nearly $26 billion per year.  The Center for Disease Control 
noted research into maternal, child, and infant health - including preterm birth - 
as an objective under the Healthy People 2020 initiative.  Intrauterine infection 
and preeclampsia are the leading known causes of preterm birth, but only 
represent 25 and 15 percent of total preterm births, respectively (Goldenberg and 
Rouse 1998; Romero, Chaiworapongsa et al. 2003).  In fact, greater than half of 
preterm births are attributed to unknown causes (Hamilton, Martin et al. 2005).  A 
recent report from The Institute of Medicine highlighted the importance of further 
research into factors contributing to preterm birth, including environmental factors 
such as pollutants.  The coincidental rise of environmental pollutants, such as 
phthalates gives further impetus to study the relationship between exposure to 
xenobiotics and adverse pregnancy outcomes such untimely parturition. 
The placenta and gestational membranes play a role in initiation of 
parturition  
The gestational membrane tissues, consisting of amniotic, chorionic and 
decidual tissue, extend from the placenta to surround the fetus and provide a 
barrier between the maternal and fetal compartments (Figure 1.2).  The amnion 
layer of the gestational membranes includes a thick collagen layer that imparts 
strength and flexibility to the membranes. The proximity of the gestational 
membranes to the myometrium allows for transfer of secreted factors between 
these tissues.  Trophoblast cells provide a barrier between fetal and maternal 
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blood flow, and contribute structural integrity to the placenta and gestational 
membranes (Figure 1.2).  In addition to providing structural integrity, the 
trophoblasts produce protein and steroid hormones throughout gestation.  
Placental and gestational membrane chorionic trophoblasts also synthesize and 
secrete inflammatory mediators throughout gestation, including prostaglandins 
and pro-inflammatory cytokines.  Other resident cells of the gestational 
membranes and placenta, including decidual macrophages, placental Hofbauer 
macrophages (Figure 1.2), amnion fibroblasts, and amnion epithelial cells, 
contribute to synthesis and secretion of prostaglandins and pro-inflammatory 
cytokines as well.   
Measurable levels of MEHP are found in the gestational compartment 
Following ingestion, DEHP is absorbed by the intestinal epithelium and rapidly 
hydrolyzed by lipases to MEHP (Rusyn, Peters et al. 2006).   Consequently, 
blood is the primary vehicle for exposure to MEHP as distal organs, including the 
placenta and gestational membranes, are exposed primarily to MEHP through 
circulating blood.  Measureable concentrations of MEHP have been found in 
maternal blood, cord blood, placenta, and amniotic fluid with the highest 
concentrations measured in maternal and cord blood. Specifically, median cord 
blood concentrations ranging from 1.8 to 35 !M, and median maternal blood 
concentrations ranging from 42.6 !M have been detected in Italian and Chinese 
cohorts, respectively (Latini, Del Vecchio et al. 2006; Lin, Zheng et al. 2008).    At 
term, between 450 and 650 ml of blood per minute circulates through the 
placenta, therefore, circulating MEHP represents a significant source of exposure 
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for the gestational compartment (Edman, Toofanian et al. 1981).   The 
concentrations of MEHP used in the present study (10-180 !M) are 
physiologically relevant and within an order of magnitude of MEHP 
concentrations measured in human maternal and cord blood.  
Pro-inflammatory cytokines and prostaglandins mediate normal and 
preterm parturition  
Both preterm and normal human parturition are associated with increased 
pro-inflammatory cytokine and prostaglandin synthesis and release from cells of 
the gestational compartment.  Specifically, increased amniotic fluid 
concentrations of the pro-inflammatory cytokines IL-1!, IL-6 and TNF-" and the 
prostaglandins PGE2 and PGF2" are associated with preterm birth (Romero, 
Manogue et al. 1989; Hillier, Witkin et al. 1993; Carroll, Abbas et al. 1995; Lee, 
Park et al. 2009; Menon, Fortunato et al. 2011).  This activation of the 
inflammatory response is central to the pathogenesis of intrauterine infection, the 
leading known cause of preterm birth.  Elevated  pro-inflammatory cytokines and 
prostaglandins are observed in the amniotic fluid of preterm birth cases with 
intrauterine infections (Keelan, Blumenstein et al. 2003).  Furthermore, exposure 
to the pro-inflammatory stimulus lipopolysaccharide (LPS) increases pro-
inflammatory cytokine and prostaglandin release from gestational tissues and 
induces preterm birth in mice (Miller and Loch-Caruso 2010; Phillippe, Diamond 
et al. 2011).  Preceding labor, the amnion, chorion, and decidua of the 
gestational membranes, in addition to resident immune cells of the placenta, 
participate in production of pro-inflammatory cytokines and prostaglandins.  Pro-
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inflammatory cytokines are secreted proteins that act through autocrine and 
paracrine mechanisms to initiate inflammatory events, including recruitment of 
circulating leukocytes to sites of infection. Prostaglandins represent a class of 
lipid mediators that have pleiotropic physiological functions in nearly every tissue.  
These functions range from vasodilation/vasoconstriction to platelet function and 
cytoprotection (Miller 2006). During pregnancy, pro-inflammatory cytokines 
stimulate bioactive prostaglandin synthesis through induction of the prostaglandin 
catabolic enzyme COX-2 (Hansen, Keelan et al. 1999).  COX-2 synthesizes 
prostaglandin E2 (PGE2) and prostaglandin F2" (PGF2"), which bind to 
excitatory receptors in the uterus to initiate myometrial contractions (Olson 2003).  
Inhibition of prostaglandin synthesis through COX-2 inhibition delays pregnancy 
and prevents preterm labor in rodents, and in vivo or in vitro exposure to 
bioactive prostaglandins stimulates myometrial contractions (Wikland, Lindblom 
et al. 1984; Lee, Kim et al. 2003; Fischer, Hutchinson et al. 2008).   In addition to 
their role in prostaglandin synthesis, pro-inflammatory cytokines also stimulate 
expression and activation of matrix metalloproteinases and activation of 
apoptosis, contributing to gestational membrane weakening and cervical ripening 
(Vadillo-Ortega and Estrada-Gutierrez 2005).  In summary, pro-inflammatory 
cytokine release from gestational tissues stimulates prostaglandin synthesis, 
apoptosis, and activation of matrix-metalloproteinases to promote membrane 




DEHP exposure is associated with inflammation and induction of 
inflammatory mediators 
In humans, urinary metabolites of DEHP are associated with increases in 
urinary markers of inflammation, including C-reactive protein and absolute 
neutrophil count (Ferguson, Loch-Caruso et al. 2011; Meeker and Ferguson 
2011).Consistent with an observed increase in inflammatory markers in humans 
exposed to DEHP, airway inflammation and allergic responses have also been 
observed in DEHP-exposed humans and animals (Deutschle T 2008, Kolarik B).   
 Exposure to DEHP or its metabolite MEHP stimulates release and 
synthesis of inflammatory mediators that are known to be associated with 
preterm labor. MEHP treatment of primary neonatal neutrophils, rat alveolar 
macrophages, murine monocyte-macrophages, human lung epithelial cells, and 
mouse Leydig cells increases pro-inflammatory cytokine release (Jepsen, 
Abildtrup et al. 2004; Rakkestad, Holme et al. 2010; Vetrano, Laskin et al. 2010).  
Furthermore, MEHP treatment increases release of the bioactive prostaglandin 
PGF2" in cultured bovine ovarian and endometrial cells, and increases 
expression of the prostaglandin catabolizing enzyme COX-2 in spermatocytes 
and rat and human mast cells (Ledwith, Pauley et al. 1997; Onorato, Brown et al. 
2008; Oh, Lim et al. 2010; Wang, Shang et al. 2010; Oh and Lim 2011).   
 Of direct relevance to the present work is the finding that DEHP exposure 
(750 or 1500 mg/kg/day oral gavage) decreases COX-2 expression and total 
prostaglandin concentration in rat placental tissue (Xu, Agrawal et al. 2008).  The 
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findings from the latter study are contrary to studies in other species and organ 
systems demonstrating increased COX-2 and prostaglandins with DEHP or 
MEHP exposure.  For example, MEHP treatment increases PGE2 release from 
cultured bovine ovarian and endometrial cells, and increases COX-2 expression 
in spermatocytes and rat and human mast cells (Ledwith, Pauley et al. 1997; 
Onorato, Brown et al. 2008; Oh, Lim et al. 2010; Wang, Shang et al. 2010; Oh 
and Lim 2011).  Differences could be due to species or organ system differences 
in prostaglandin pathway responses to MEHP.  Furthermore, the doses of DEHP 
used in the latter study exceeded the 95th percentile of estimated adult human 
intake of 21 !g/kg/day by approximately four orders of magnitude (Koch, Preuss 
et al. 2006).   Further studies testing the effects of physiologically relevant 
concentrations of MEHP on prostaglandin synthesis and pro-inflammatory 
cytokine release in human gestational tissues and cells would provide additional 
insight into the role of MEHP in stimulation of inflammatory responses during 
pregnancy.    
Oxidative stress is associated with preterm and normal term parturition 
Oxidative stress is characterized by an excess of damaging reactive 
oxygen species (ROS) resulting from an imbalance between oxidant species 
generation and cellular antioxidant capacity.  Excess ROS can result in damage 
to macromolecules, including lipid peroxidation, oxidative DNA adduct formation, 
and protein oxidation.  Exposure to pollutants that induce oxidative stress, 
including air pollution, cigarette smoke, and organochlorine pesticides increases 
risk for preterm birth (Cnattingius 2004; Malmqvist, Rignell-Hydbom et al. 2011; 
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Chang, Reich et al. 2012).  Specifically, exposure to organochlorine pesticide 
residues during pregnancy is associated with elevated cord blood concentrations 
of malondialdehyde and decreased cord blood concentrations of reduced 
glutathione, indicative of lipid peroxidation and antioxidant depletion (Pathak, 
Suke et al. 2010). 
Oxidative stress in the cells and tissues of the gestational compartment is 
linked to preterm labor and normal human parturition.  Normal human parturition 
corresponds with increased protein oxidation and lipid peroxidation and 
decreased antioxidants in myometrial tissues (Khan, Matharoo-Ball et al. 2010).  
Similarly, preterm labor is associated with oxidative stress markers including the 
lipid peroxidation products F2-isoprostane and malondialdehyde, and decreases 
in the antioxidant enzyme glutathione peroxidase (Fainaru, Almog et al. 2002; 
Mocatta, Winterbourn et al. 2004).  Furthermore, increased levels of the urinary 
oxidative stress markers 8-isoprostane and 8-hydroxydeoxyguanosine (8-OHdG) 
in early or mid-gestation are predictive of preeclampsia and decreased gestation 
length (Peter Stein, Scholl et al. 2008; Hsieh, Chen et al. 2012).   Although the 
latter observations suggest that oxidative stress events correspond with preterm 
and normal term parturition, the function of these events in initiation of parturition 
is not fully understood.  
 Evidence suggests that reactive oxygen species generation in cells of the 
gestational compartment may activate cellular pathways relevant to preterm birth 
including NF-#B, pro-inflammatory cytokine response, and apoptosis. 
Specifically, antioxidant pretreatment prevents LPS-stimulated release of pro-
10 
 
inflammatory cytokines and NF-kB activation in gestational membrane explant 
cultures, and prevents LPS-induced preterm labor in mice (Buhimschi, Buhimschi 
et al. 2003; Lappas, Permezel et al. 2003).  In addition, oxidative insult in 
cultured placental and chorionic membrane trophoblasts initiates apoptosis 
(Rosado-Berrios, Velez et al. 2011).  The latter studies provide compelling 
evidence to suggest that parturition relevant pathways, including apoptosis, pro-
inflammatory cytokine release, and lipid mediator synthesis may be mediated 
through oxidative stress.  Furthermore, these studies suggest that oxidative 
stress may have more than an associative relationship to parturition events and 
that, in fact, oxidative insult may be capable of initiating these events.   
DEHP exposure induces oxidative stress responses 
Both apoptosis and oxidative stress are mechanisms common to the toxicity of 
many environmental pollutants, including MEHP.  In humans, urinary MEHP or its 
oxidized metabolites are correlated with urinary markers of oxidative stress 
including decreased bilirubin and increased gamma glutamyltransferase (GGT), 
malondialdehyde (MDA), and 8-hydroxydeoxyguanosine (8-OHdG) (Hong, Park 
et al. 2009; Ferguson, Loch-Caruso et al. 2011; Ferguson, Loch-Caruso et al. 
2011). In vitro, MEHP treatment induces reactive oxygen species generation in 
neutrophils and cells of the liver and testes. (Rose, Rivera et al. 1999; Erkekoglu, 
Rachidi et al. 2010; Fan, Traore et al. 2010; Vetrano, Laskin et al. 2010; 
Erkeko$lu, Rachidi et al. 2011; Rosado-Berrios, Vélez et al. 2011).  Furthermore, 
MEHP toxicity in germ cells and Leydig cells of the testes is linked to decreases 
in antioxidant levels, increased oxidative DNA damage, and induction of 
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apoptosis (Richburg, Nañez et al. 2000; Kasahara, Sato et al. 2002; Hauser, 
Meeker et al. 2007; Suna, Yamaguchi et al. 2007; Erkekoglu, Rachidi et al. 
2010). Despite the evidence linking MEHP-induced oxidative stress to disease 
outcomes in the liver, immune system, and male reproductive system, little 
attention has been given to the role of oxidative stress in adverse female 
reproductive outcomes. 
Research Objectives 
Based on the evidence that MEHP induces oxidative stress and inflammatory 
mediator synthesis in other organ systems, and because MEHP exposure is 
associated with adverse pregnancy outcomes in humans, we hypothesize that 
MEHP activates cellular responses relevant to preterm birth in human 
gestational tissues and cells.  The specific aims of this project are to: 1) 
Examine the effects of MEHP treatment on reactive oxygen species generation, 
oxidative DNA damage, antioxidant gene expression, and apoptotic cell death in 
human placental trophoblast cells; and 2) Examine the effects of in vitro MEHP 
treatment on prostaglandin synthesis and pro-inflammatory cytokine release in 
primary human placental and decidual macrophages, human placental 













Figure 1.1A.  Structure of diethylhexyl phthalate (DEHP). 






Figure 1.1B.  Structure of monoethylhexyl phthalate (MEHP). 















Figure 1.2. Anatomy of the pregnant uterus.   
Diagram adapted from A.D.A.M Interactive Anatomy 2009.  Gestational membrane histology 


















Figure 1.3.  Model of parturition initiation.  Pro-inflammatory cytokine release from 
gestational tissues stimulates prostaglandin synthesis, apoptosis, and activation of 
matrix-metalloproteases to promote membrane rupture, uterine contractions, cervical 
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Mono-2-ethylhexyl phthalate-induced oxidative stress 
in human placental cells 
 
Abstract 
Di-2-ethylhexyl phthalate (DEHP) is an environmental contaminant used as a 
plasticizer in polyvinyl chloride products. Mono-ethylhexyl phthalate (MEHP), the 
active metabolite of DEHP, increases reactive oxygen species production and 
decreases antioxidants in liver, kidney and testicular cells. To investigate whether 
placenta is a potential target of MEHP, we evaluated MEHP effects on reactive 
oxygen species generation, oxidative DNA adduct formation, apoptosis and 
expression of redox-sensitive genes in the human extravillous trophoblast cell 
line HTR-8/SVneo (HTR-8). HTR-8 cells were treated with MEHP concentrations 
ranging from 10-180 !M. Solvent controls were exposed to dimethyl sulfoxide 
(DMSO; 0.05% v/v).  Stimulation of oxidant species generation was assessed by 
formation of the fluorescent product 2,7"-dichlorofluorescein (DCF) in HTR-8 cells 
loaded with 5-(and-6)-carboxy-2´7´-dichlorodihydrofluorescein diacetate (H2DCF-
DA) and exposed for 1 h to MEHP.  Treatment with 45, 90, or 180 !M MEHP for 
1 h significantly increased oxidant species after 1 h of exposure. In other 
experiments, HTR-8 cells were loaded with H2DCF-DA, pretreated for 1 h with or 
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without the iron chelator deferoxamine mesylate (DFO; 1 mM), and then exposed 
for 1 h to MEHP.  Pretreatment with DFO reduced MEHP-induced DCF 
fluorescence. To measure oxidized thymine adduct formation, cells were treated 
24 h with MEHP. DNA then was extracted, and concentrations of oxidized 
thymine were quantified using mass-spectrometry. Treatment with 180 !M MEHP 
increased oxidized thymine adduct formation two-fold compared with solvent 
controls. To assess apoptosis, caspase 3/7 activation was measured using a 
luminescence-based assay following 24-h exposure to MEHP.  A 1.5-fold 
increase in caspase 3/7 activation was observed with 180 !M MEHP treatment 
(p#0.05). RNA expression of 84 redox-sensitive genes was measured in cells 
exposed to MEHP for 4, 8 or 24 h using a qRT-PCR array (n=3 experiments). 
Using qqRT-PCR, we validated the findings of the array for those genes with 
significant mRNA expression changes that were approximately two–fold or more 
with 180 !M MEHP treatment: AOX1, DHCR24, GLRX2, PRNP, SCARA3, 
TXNRD1, and PTGS2.   Treatment with 180 !M MEHP significantly increased 
mRNA expression of PTGS2, GLRX2, and TXNRD1 and significantly decreased 
mRNA expression of DHCR24. These results show that MEHP induces an 








 Diethylhexyl phthalate (DEHP) is primarily used as a plasticizer in the 
manufacturing of polyvinyl chloride (PVC) and is found in a wide variety of 
consumer products including food packaging, intravenous medical tubing, 
clothing, furniture and automobile upholstery, and children's toys.  DEHP is not 
covalently bound to PVC products and as a result leaches into the environment 
where it collects in dust particles or in food contained in PVC plastic.  DEHP is a 
pervasive environmental contaminant, present in 733 out of 1613 Environmental 
Protection Agency (EPA) National Priority List sites.  Exposure to DEHP is 
widespread and frequent in the US population. Data collected from the National 
Health and Nutrition Examination Survey (NHANES) datasets from 1999 to 2006 
show measurable levels of monoethylhexyl phthalate (MEHP), the active 
metabolite of DEHP, in 98% of urine samples analyzed.  Because DEHP is 
rapidly metabolized to its active monoester metabolites and excreted in the urine, 
the latter finding suggests that human exposure to DEHP is a widespread and 
daily occurrence. 
 Exposure to DEHP is linked to adverse pregnancy outcomes.  In humans, 
higher concentrations of MEHP in urine or cord blood samples of pregnant 
women are associated with low birth weight, increased risk for preterm birth, 
decreased gestation length, and pregnancy loss (Latini, De Felice et al. 2003; 
Lin, Zheng et al. 2008; Meeker, Hu et al. 2009; Toft, Jonsson et al. 2011).   
Furthermore, MEHP has been detected in placenta, amniotic fluid and cord blood 
of humans (Mose, Mortensen et al. 2007; Wittassek, Angerer et al. 2009; Lin, Ku 
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et al. 2011).  The latter two findings suggest that the gestational compartment 
may be a target of MEHP toxicity.  Despite the evidence linking DEHP exposure 
to adverse pregnancy outcomes, the mechanism underlying these associations is 
unclear.   
Oxidative stress, defined as an imbalance between the production of 
damaging reactive oxygen species (ROS) and cellular antioxidant defenses, and 
apoptosis in cells of the gestational compartment are closely linked to the 
pathology of adverse pregnancy outcomes, as evidenced by increased markers 
of apoptosis and oxidative stress in pathological pregnancies. For example, 
placental trophoblasts from pregnancies complicated by preeclampsia, 
intrauterine growth restriction, and miscarriage express higher levels of oxidative 
stress and apoptotic markers compared to normal controls (DiFederico, 
Genbacev et al. 1999; Hempstock, Jauniaux et al. 2003; Tomas, Prusac et al. 
2011).  Furthermore, increased levels of urinary oxidative stress markers early in 
pregnancy predict preeclampsia and shortened gestation length (Peter Stein, 
Scholl et al. 2008; Bazavilvaso-Rodríguez, Hernández-Valencia et al. 2011; 
Miranda Guisado, Vallejo-Vaz et al. 2011).   
Apoptosis and oxidative stress are mechanisms common to the toxicity of 
many environmental pollutants, including MEHP.  In humans, urinary MEHP or its 
oxidized metabolites are associated with urinary markers of oxidative stress 
(Ferguson, Loch-Caruso et al. 2011; Ferguson, Loch-Caruso et al. 2011).  In vitro 
MEHP treatment of neutrophils, Kupfer cells and Leydig cells generates (ROS) 
(Rose, Rivera et al. 1999; Erkekoglu, Rachidi et al. 2010; Fan, Traore et al. 2010; 
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Vetrano, Laskin et al. 2010; Erkeko$lu, Rachidi et al. 2011; Rosado-Berrios, 
Vélez et al. 2011).  Furthermore, MEHP toxicity in germ cells or Leydig cells of 
the testes is linked to decreased levels of GSH and ascorbic acid, decreased 
thioredoxin reductase expression, decreased glutathione peroxidase activity, 
increased DNA damage, and induction of apoptosis (Richburg, Nañez et al. 
2000; Kasahara, Sato et al. 2002; Hauser, Meeker et al. 2007; Suna, Yamaguchi 
et al. 2007; Erkekoglu, Rachidi et al. 2010).  In human first trimester trophoblast 
cells, in vitro DEHP treatment increases apoptosis and expression of the pro-
apoptotic gene BAX2 (Wang, Shang et al. 2010). The biological relevance of the 
latter study is challenged, however, by the fact that DEHP is rapidly metabolized 
to MEHP by lipases in the gut or lungs after ingestion or inhalation, respectively, 
converting most DEHP to MEHP before distribution to distal organs of the body, 
including the placenta (Frederiksen, Skakkebaek et al. 2007). 
 In the present study, we hypothesize that MEHP induces oxidative stress 
responses and subsequent apoptotic cell death in cells of the gestational 
compartment. We examined the effects of MEHP treatment on ROS generation, 
oxidative DNA damage, redox-sensitive gene expression, and apoptotic cell 
death in HTR-8/SVneo (HTR-8) cells, a human first trimester extravillous 






Materials and Methods 
Reagents.  We purchased carboxy-dichlorodihydrofluorescein diacetate (H2DCF-
DA), Hoechst dye, phosphate buffered saline (PBS), and Hank’s balanced salt 
solution (HBSS) from Invitrogen Life Technologies; dimethyl sulfoxide (DMSO), 
deferoxamine mesylate, tert-butyl hydroperoxide (TBHP), and camptothecin from 
Sigma-Aldrich (St. Louis, MO, USA); and MEHP from Accustandard (New Haven, 
CT).   
Cell culture and treatment.  The HTR-8 cells were a gift from Dr. Charles 
Graham (Queens University, Ontario, Canada).  The HTR-8 cells were isolated 
from first trimester human placenta and immortalized with SV40 antigen 
(Graham, Hawley et al. 1993).  Similar to their primary counterparts, HTR-8 cells 
express human chorionic gonadropin, stain positive for the epithelial marker 
cytokeratin-7, and retain migratory capabilities in culture (Graham, Hawley et al. 
1993).  Cells between passages 71 and 84 were cultured in RPMI 1640 medium 
with L-glutamine without phenol red (Gibco; Grand Island, NY, USA), 
supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA) and 
1% penicillin/streptomycin (Gibco) at 37°C in a 5% CO2 humidified atmosphere.  
For most experiments, cells were grown to a confluence of 70-80% before 
treatment.  For the dichlorofluorescein (DCF) plate-based assay, cells were 
grown to a confluence of 80-90% before treatment. From stock solutions of 392 
!M MEHP in DMSO, exposure media solutions of 10, 22.5, 45, 90, or 180 !M 
MEHP were made immediately prior to initiating the experiment. The DMSO 
concentration was 0.05% for all exposure groups. 
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ROS measurement.  Stimulation of ROS generation was assessed 
spectrofluorometrically using the dichlorofluorescein (DCF) assay. The HTR-8 
cells were seeded at a density of 30,000 cells per well in a 96-well black, clear 
bottom plate and incubated at 37°C in a 5% CO2 atmosphere for 24 h.  Cells 
were then pre-incubated with 100 !M H2DCF-DA in HBSS for 60 min at 37 °C.  
The dye solution was then removed, the cultures were rinsed with HBSS, and the 
cells were then treated with dimethyl sulfoxide (DMSO; 0.05% v/v; solvent 
control), or with 10, 22.5, 45, 90, or 180 !M MEHP in replicates of 6 for 60 min. 
Treatment with the prototypical chemical oxidant tert-butyl hydroperoxide 
(TBHP;100 !M)  served  as a positive control.  After washing with HBSS and 
then adding fresh HBSS back to the cells, fluorescence was measured from the 
bottom of the culture plate with the Molecular Devices SpectraMax Gemini M2e 
at an excitation wavelength of 492 nm and emission wavelength of 522 nm.  In 
previous experiments, we determined that MEHP  in 0.05% DMSO showed no 
effects on DCF fluorescence in cell-free HBSS buffer compared to DMSO alone  
(Appendix A, Figure A1.) 
 Inhibition of DCF fluorescence was assayed by fluorescence microscopy.  
The HTR-8 cells were seeded at a density of 400,000 cells per well in a 6-well 
plate and cultured for  24 h before incubation with 100 !M H2DCF-DA in HBSS 
for 1 h.  After removal of the dye solution and rinsing with HBSS, cultures were 
incubated for an additional 1 h with 1 mM deferoxamine mesylate (DFO) as an 
antioxidant treatment. Previously, we had determined that 1mM deferoxamine 
was not cytotoxic to HTR-8 cells, using the Promega Cyquant viability assay 
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(data not shown).  Cultures were exposed to HBSS alone, 0.05% DMSO (solvent 
control), or 180 !M MEHP for 90 min, and then counterstained with the nucleic 
acid stain Hoechst for 5 min. Using an EVOS digital inverted fluorescence 
microscope, intracellular DCF fluorescence was visualized at 470 nm excitation 
and 525 nm emission, and Hoechst stain was visualized at 357 nm excitation and 
447 nm emission.  Five images per treatment were taken, one image in each of 
the four quadrants and one in the center of the well.   
Oxidized thymine measurement.  HTR-8 cells were seeded at a density of 3.5-
4 x 106 cells in 175 cm2 flasks.  After 24 h of incubation, cells were treated with 
DMSO (solvent control), 50 !M TBHP, 90 !M MEHP, or 180 !M MEHP for 24 h.  
Genomic DNA was extracted using the Qiagen Blood and Cell Culture DNA Midi 
Kit following the manufacturer's protocol.  Oxidized thymine (oT) was measured 
in collaboration with the Giese laboratory at Northeastern University as described 
in detail elsewhere by the following sequence of steps: (1) DNA was digested to 
nucleotides with nuclease P1 and phosphodiesterase; (2) the enzymes were 
removed by ultrafiltration; (3) the nucleotides were separated by reversed-phase 
HPLC and fractions eluting between dCMP and TMP were collected; (4) the 
nucleotides in the collected fraction were converted to phosphorimidazolides with 
a pair of isotopologue (do,d4) benzoylhistamine (BH) reagents in the presence of 
a water-soluble carbodiimide; (5) cation exchange filtration was conducted to 
remove residual reagents; (6) capillary reversed-phase HPLC was conducted by 
spotting onto a MALDI target followed by matrix addition containing an internal 
standard (BH-labeled 1,N6-etheno-dAMP) ; and (7) BH-labeled-oT and internal 
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standard were measures by MALDI-TOF-MS with structural confirmation by 
MALDI-TOF/TOF-MS (Wang, Fisher et al. 2012).   
Caspase 3/7 activity assay.  We measured caspase 3/7 activity in cell lysates 
using the Caspase-Glo 3/7 luminescent assay (Promega) following the 
manufacturer's recommended protocol.  The HTR-8 cells were seeded at a 
density of 10,000 cells per well in a 96-well white, clear-bottom plate 24 h prior to 
treatment.  Cells were then treated with medium alone, DMSO (solvent control), 
MEHP (22.5, 45, 100, or 180 µM), or 4 µM camptothecin (positive control) for 4, 
8, or 24 h.  We observed no significant differences between medium alone and 
solvent control (DMSO) cultures (data not shown). 
 Cytotoxicity and viability assay.  The MultiTox-Glo Multiplex Cytotoxicity 
Assay (Promega, Madison, WI, USA) was used to quantify cytotoxicity using a 
luminescent substrate for extracellular, dead-cell protease, and to quantify 
viability using a fluorescent substrate for intracellular proteases, following the 
manufacturer's recommended protocol. The HTR-8 cells were seeded at 10,000 
cells/well in a 96-well, white, clear-bottomed plate 24 h prior to treatment. Cells 
were treated with medium alone, DMSO (solvent control), MEHP (22.5, 45, 90, or 
180 !M), or 4 !M camptothecin (positive control) for 24 or 48 h. Fluorescence 
was measured using the SpectraMax M2 Multi-Mode Microplate Reader 
(Molecular Devices) and luminescence was measured using the Glomax Multi 
Plus Detection System (Promega).  
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Oxidative stress and antioxidant response gene array and qRT-PCR 
validation.  Because MEHP stimulated reactive ROS generation as assessed by 
DCF fluorescence, we evaluated changes in gene expression in the oxidative 
stress response pathway using the Oxidative Stress and Antioxidant PCR Array 
from SABiosciences. The HTR-8 cells were seeded at a density of 400,000 cells 
per well in a 6-well cell culture plate and allowed to adhere for one day.  Cells 
were treated with medium alone, DMSO (solvent control), MEHP (90, or 180 !M) 
or 50 !M TBHP.  After 4, 8, or 24 h of exposure, RNA was extracted using the 
RNeasy Plus Mini Kit (Qiagen), and cDNA was synthesized from 1 !g of total 
RNA using the RT2 First Strand Kit (SABiosciences) following the manufacturers' 
recommended protocols.  For the array, the cDNA from solvent control and 180 
!M MEHP treatments was analyzed using the ABI 7900HT Sequence Detection 
System following the SABiosciences recommended protocol.  Fold changes were 
calculated using the %%CT method, normalizing each sample to the average CT 
of all housekeeping gene CT values.  Mean %CT values were compared between 
groups using paired t-tests from the Limma package of Bioconductor (Smyth 
Gordon 2004). The resulting p-values were adjusted for multiplicity using the 
Benjamini and Hochberg false discovery rate method (Benjamini and Hochberg 
1995).  Using qRT-PCR, we validated the findings of the array for those genes 
with significant mRNA expression changes that were approximately two–fold or 
more with 180 !M MEHP treatment: AOX1, DHCR24, GLRX2, PRNP, SCARA, 
TXNRD1, and PTGS2. qRT-PCR was performed on these seven genes using 
samples from cells treated with medium alone, DMSO (solvent control), 90 or 
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180 !M MEHP, or 50 !M TBHP for 24 h.  Using the SABiosciences RT2 First 
Strand Kit, cDNA was made from 1 !g of mRNA.  PCR reactions were run with 
the same SABiosciences primers used in the Oxidative Stress and Antioxidant 
PCR Array and SYBR green mastermix (SABiosciences), with 2-5 !L of 
template. qRT- PCR reactions were run on the Bio-Rad CFX96 Real Time C1000 
thermal cycler following the manufacturer's recommended protocol.   
Statistical analysis.  Multiple group comparisons were carried out using a 
paired one-way ANOVA or two-way ANOVA for two-factor analyses and pairwise 
comparisons were carried out using paired t-tests, with p<0.05 as the 
significance cutoff.  Data are expressed as the mean ± SD of between 3 and 5 
experiments.   
 
Results 
Cellular generation of reactive chemical species.  Treatment of HTR-8 cells 
with 45, 90 or 180 µM MEHP for 1 h resulted in a significant increase in relative 
fluorescence units over the solvent control, indicating increased H2DCF-DA 
oxidation (Figure 2.1).  Interestingly, this increase was larger than that observed 
with the prototypical chemical oxidant, TBHP (100 µM).  When cells were 
pretreated with the iron chelator, deferoxamine mesylate, DCF fluorescence was 
visibly decreased in cells treated with 180 !M MEHP, suggesting a Fenton-
dependent production of hydroxyl radical from hydrogen peroxide with MEHP 
treatment (Figure 2.2).  Using microscopy, we observed no differences in 
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fluorescence when cells were incubated in HBSS alone or HBSS with 0.05% 
DMSO (data not shown). 
Oxidized thymine (oT) formation.  Figure 2.3A shows oxidation of thymine in 
three separate experiments.  Treatment with MEHP for 24 h increased oT 
approximately 20% with 90 !M and approximately 80% with 180 !M MEHP, on 
average.  An increase in oT of approximately 200% was also observed with 50 
!M TBHP treatment.  To obtain these results, DNA from the samples was 
digested to nucleotides and the appropriate HPLC fraction was subjected to 
labeling with a mass tag prior to analysis by mass spectrometry.  Samples were 
paired, where one sample (after HPLC collection) was labeled with a nonisotopic 
(d0) tag, whereas the other sample was labeled with a corresponding isotopic (d4) 
tag, prior to combining the samples to assess the relative amounts of oT.  At the 
same time, the absolute amounts were determined based on the internal 
standard (BH-labeled 1,N6-etheno-dAMP).   In these experiments, the tags were 
also reversed.  Representative data is shown in Figure 2.3B.   
Caspase 3/7 activity.  MEHP treatment significantly increased caspase 3/7 
activation by approximately 80% at 24 h (Figure 2.4; p=0.01). This increase was 
modest, though, in comparison to the positive control (4 !M camptothecin).  We 
observed no significant treatment effects at 4 h or 8 h, and no differences in 
caspase 3/7 activity in controls treated with medium alone compared with 0.05% 
DMSO (solvent control) at 4, 8, or 24 h (data not shown).  
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Cytotoxicity and cell viability.  MEHP treatment had no effect on cytotoxicity, at 
either 24 h or 48 h, as assessed by an extracellular protease activity assay for 
membrane integrity (data not shown).  We observed no differences in cytotoxicity 
or viability with medium alone compared with 0.05% DMSO at 24 h or 48 h.  
Treatment with 180 µM MEHP, but not lower MEHP concentrations, significantly 
decreased cell viability at 48 h but not 24 h, as measured by intracellular 
protease activity (Figure 2.5; p<0.001).    
mRNA expression.  We identified seven genes with the Oxidative Stress and 
Antioxidant Response Gene Array whose mRNA expression significantly 
changed two-fold or more with 180 µM MEHP treatment compared to solvent 
control (Table 2.1; adjusted p value<0.05).  The results of the array showed that 
MEHP treatment significantly increased expression of PTGS2 at 4, 8, and 24 h, 
and GLRX2, PRNP, TXNRD1, and AOX1 at 24 h; whereas expression 
significantly decreased for SCARA3 and DHCR24 at 24 h.  With qRT-PCR 
analysis of RNA extracts from samples treated for 24 h, we confirmed MEHP-
stimulated changes in gene expression for four of these genes:  increased 
expression of PTGS2,  GLRX2, TXNRD1 and decreased expression of DHCR24 
(p-value=0.001, 0.01, 0.048, and 0.002, respectively) (Figure 2.6 A, B, C, and D, 
respectively).  Although the expression changes observed with MEHP treatment 
were not significant for SCARA, PRNP, or AOX1 (Figure 2.6E, F, and G, 
respectively), we observed the same directional changes in expression as were 
observed with the qRT-PCR array. Cells exposed to 180 !M MEHP had similar 
magnitude changes in gene expression as were observed with 50 !M TBHP; 
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however, these groups were not compared by statistical analysis due to low 
sample size in the TBHP treatment group.  Likewise, statistical comparisons 
were not performed between the solvent (DMSO) control group and the control 




 The goal of the current study was to investigate oxidative stress as a 
cellular mechanism by which MEHP exposure may contribute to adverse 
pregnancy outcomes.  Our findings demonstrate that MEHP induces oxidative 
stress responses in human placental cells, specifically, ROS production, 
oxidative DNA damage, and modification of redox-sensitive gene expression.  
The direction and magnitude of redox-sensitive gene expression changes 
observed with MEHP treatment were comparable to those observed with tert-
butyl hydroperoxide (TBHP) treatment, suggesting that MEHP acts similarly to a 
prototypical chemical oxidant to modify antioxidant and redox sensitive gene 
expression in the HTR-8 cells.  Notably, MEHP treatment strongly induced 
PTGS2, the gene for COX-2, suggesting that MEHP may stimulate synthesis of 
prostaglandins necessary for stimulation of myometrial contractions and 
ultimately, parturition.   
 This is the first study to document MEHP-stimulated oxidative stress 
responses in cells of the gestational compartment, consistent with previous 
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reports that MEHP stimulates ROS production  and oxidative DNA damage are 
observed in other cell types.  In humans, urinary levels of MEHP are correlated 
with increased DNA damage in sperm.  In vitro, MEHP treatment induces DNA 
damage in human liver carcinoma cells at concentrations ranging from 25 to 100 
µM, and human lymphocytes at concentrations ranging from 100-2500 µM 
(Yang, Zhou et al. ; Kleinsasser, Harreus et al. 2004; Hauser, Meeker et al. 
2007). In addition, in vitro MEHP treatment stimulates ROS generation in human 
prostate adenocarcimona cells at a concentration of 3 !M and human 
neutrophils, human lymphoblast  cells, and mouse Leydig cells at concentrations 
ranging from 100-500 µM (Zhao, Ao et al. ; Erkekoglu, Rachidi et al. 2010; 
Erkekoglu, Rachidi et al. 2010; Rosado-Berrios, Vélez et al. 2011).   
Previous studies demonstrating that increased urinary 8-OHdG is 
predictive of shortened gestation length and low birth weight highlight the 
relevance of our findings to the etiology of adverse pregnancy outcomes.  The 
intrauterine environment is maintained at relatively low-oxygen concentrations in 
order to support proper development of the placenta.  As a consequence, early 
trophoblast cells tend to express lower levels of antioxidants (Davis and Auten 
2010).  This suggests that first trimester trophoblasts may be more susceptible to 
oxidative stress from chemicals that increase the generation of ROS compared to 
third trimester trophoblast cells. 
     In the HTR-8 cells, MEHP increased activity of the executioner caspases 3 
and 7 at 24h and decreased cell viability at 48h, suggesting apoptotic activation 
and subsequent cell death.  This finding is supported by in vitro studies 
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evidencing apoptosis with MEHP concentrations ranging from 196-1000 !M  in 
immune cells, testicular germ cells, Sertoli cells, and mouse embryonic stem 
cells (Yao, Lin et al. 2007; Lim, Kim et al. 2009; Vetrano, Laskin et al. 2010; 
Rosado-Berrios, Vélez et al. 2011).   Interestingly, MEHP-induced apoptosis is 
dependent on ROS in male germ cells and TK6 human lymphoblast cells and, 
similarly, oxidative insult in cultured first-trimester placental trophoblasts and term 
chorionic membrane trophoblasts triggers apoptosis (Moll, Jones et al. 2007; 
Rogers, Ouellet et al. 2008; Yuan, Ohyama et al. 2008; Rosado-Berrios, Velez et 
al. 2011).  ROS and oxidative DNA damage, both of which were increased with 
MEHP in the HTR-8 cells, can activate caspases directly by interaction with 
redox-sensitive cysteines on caspases or by p53 induction, respectively (Circu 
and Aw 2010).  Although not directly measured in this study, we suggest that the 
increased caspase activity observed at 24 h may be dependent on the MEHP-
stimulated generation of ROS in HTR-8 cells.    Because apoptosis of first 
trimester placental trophoblasts and later-gestation chorionic laeve trophoblasts 
is linked to preeclampsia and preterm birth, and our results show increased 
activation of caspases, we suggest that apoptosis may be implicated in MEHP-
induced adverse pregnancy outcomes.  We observed decreased cell viability with 
180 !M MEHP at 48 h without any measurable cytotoxic effects.   A possible 
explanation for this may be that extracellular proteases released into cell medium 
do not remain viable for longer treatment periods and therefore may not be the 
most suitable indicator of cytotoxicity at later time points.   
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           Differential antioxidant expression is observed in gestational tissues of 
pregnancies complicated by preeclampsia, IUGR, and miscarriage (Sahlin, Wang 
et al. 2000; Biri, Kavutcu et al. 2006; Hoegh, Borup et al. 2010).  Our gene 
expression array results demonstrate that MEHP treatment resulted in a robust 
induction of the dual peroxidase and oxidase PTGS2, modest changes in 
antioxidant genes GLRX2, TXNRD1, DHCR24, PRNP, and SCARA3, and 
modest changes in the phase 1 metabolizing enzyme gene AOX1.  TXNRD1, 
PRNP, and AOX1 each contain an antioxidant response element in their 
promoter regions (Varela-Nallar, Toledo et al. 2006; Suvorova, Lucas et al. 
2009). The latter results suggest that Nrf2 may be activated as a protective 
response to ROS generated with MEHP treatment.  GLRX2 and TXNRD1, both 
classic antioxidants and oxidoreductases, confer protection from oxidative DNA 
damage, apoptosis, and cell death (Meyer, Buchanan et al. 2009).  Increased 
levels of GLRX and TXNRD protein are found in preeclamptic placentae 
compared to controls, suggesting involvement of GLRX and TXNRD proteins in 
protection of the placenta from oxidative insult (Shibata, Ejima et al. 2001). 
Increases in GLRX2 and TXNRD1 gene expression observed in this study may 
serve to protect the cell from increased ROS generated by MEHP.  AOX1 is the 
gene for aldehyde oxidase 1, a phase 1 metabolizing enzyme that transfers 
electrons to molecular oxygen, resulting in formation of radicals.  Because of the 
possibility of radical formation with aldehyde oxidase activity, we suggest that the 
observed decrease in AOX1 with MEHP treatment may be a protective cellular 
response. SCARA3, DHCR24, and PRNP have radical scavenging and cyto-
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protective functions; however, the function of these genes in the gestational 
compartment is unknown (Han, Tokino et al. 1998; Kawashiro, Fukata et al. 
2009).  The decrease observed in this study in DHCR24, the gene for 3&-
hydroxysterol-D24 reductase, which catalyzes the last step in cholesterol 
biosynthesis converting desmosterol to cholesterol, suggests that MEHP may 
interfere with steroid synthesis, which has implications for sustaining 
progesterone levels necessary for maintenance of pregnancy (Kawashiro, Fukata 
et al. 2009).  The parallel changes in the magnitude and direction of gene 
expression between 180 !M MEHP and TBHP treatment for all genes measured 
is not surprising considering that TBHP works through the Fenton reaction to 
generate hydroxyl radical from hydrogen peroxide and our results from the DCF 
assay suggest that MEHP generates hydroxyl radical through the Fenton 
reaction also.    
 Considering our observations that MEHP treatment increases both ROS 
generation and oxidative DNA damage, we expected to see more genes 
differentially expressed with MEHP.  Because the antioxidant and oxidative 
stress response array includes genes that are responsive to a wide array of 
reactive species, it may be that MEHP treatment is generating only a subset of 
these reactive species.   Furthermore, because gene expression is often 
transient and we measured expression at only three time points, some MEHP-
induced changes in expression may have been missed.  Future experiments 
could test additional time points and validate these gene expression changes 
with protein expression data.   
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 Particularly interesting is our finding that MEHP induced a robust increase 
in expression of PTGS2, the gene for cyclooxygenase-2 (COX-2) enzyme, an 
enzyme necessary for the initiation of parturition.  COX-2, the translated enzyme 
product of PTGS2, catalyzes synthesis of bioactive prostaglandins, including 
PGE2 and PGF2', which bind to excitatory receptors and stimulate myometrial 
contractions, a hallmark of labor induction.  In chorion laeve, PTGS2 mRNA 
levels are approximately seven times higher in tissues from spontaneous preterm 
labor compared to non-laboring tissues of equivalent gestational age, an 
increase comparable to the 8-fold increase that we observed with 180 !M MEHP 
compared to the solvent control in the present study (Mijovic, Zakar et al. 1998).  
In HTR-8 cells and primary extravillous trophoblast cells, COX-2 inhibition 
suppresses migration, suggesting that perturbation of COX-2 expression early in 
gestation may interfere with placentation (Horita, Kuroda et al. 2007).  The 
observed increase in PTGS2 levels with MEHP treatment is corroborated by 
studies showing increased PTGS2 mRNA expression with MEHP treatment in 
murine liver cells and increased COX-2 protein expression with MEHP treatment 
in spermatocytes and rat and human mast cells (Ledwith, Pauley et al. 1997; 
Onorato, Brown et al. 2008; Oh, Lim et al. 2010; Oh and Lim 2011).  In contrast, 
an in vivo study found that 750 and 1500 mg/kg DEHP exposure decreased 
PTGS2 mRNA and COX-2 protein expression in rat placenta.  Differences 
between the current study and previously published studies may be related to 
species differences, because differences in response to DEHP have been 
observed in studies comparing peroxisome proliferation in rat and human 
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hepatocytes  (Xu, Agrawal et al. 2008).  Furthermore, the doses of DEHP used in 
the rat study were four orders of magnitude above the 95th percentile of relevant 
human intake estimates (Koch, Preuss et al. 2006).  Further in vivo studies 
testing exposure doses that are closer to physiologically relevant concentrations 
are needed.  In addition, it is possibly that MEHP may exert differential effects in 
the in vivo context compared to in vitro.   
     We chose to use HTR-8 cells as a model to study the effects of MEHP on the 
gestational compartment because these cells exhibit normal chromosome 
numbers as compared to other immortalized cell lines from the gestational 
compartment and they have a similar phenotype compared to their primary 
counterparts (Graham, Hawley et al. 1993; Nicola, Timoshenko et al. 2005; 
Biondi, Ferretti et al. 2006; Nicola, Chirpac et al. 2008; Jovanovi( and Vi(ovac 
2009; Jovanovi(, Stefanoska et al. 2010).  It is important to note, however, that 
these cells may have a different gene expression and gene methylation profile 
compared to primary extravillous trophoblast cells (Bilban, Tauber et al. 2010; 
Novakovic, Gordon et al. 2011).  For this reason, we plan to further investigate 
the mechanisms of toxicity of MEHP which were identified in the current study in 
primary cells of the gestational compartment.    
     In the present study, we have identified oxidative stress as a mechanism by 
which MEHP may influence pregnancy outcomes using an immortalized human 
first trimester trophoblast cell line as a model.  In the future, we intend to study 
MEHP-induced oxidative stress in primary human gestational cells and tissues 
from late term pregnancies, as well as in an in vivo rodent model, with the goal of 
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identifying mechanisms that may explain the association between MEHP 
exposure and preterm birth.  Furthermore, based on our finding of increased 
PTGS2 gene expression with MEHP treatment, we are interested in studying the 
effects of MEHP treatment on prostaglandin synthesis pathways, specifically, 
PGE2 and PGF2!, in primary human gestational tissues and cells.  The findings 
from the current study warrant future epidemiological studies of oxidative stress, 
apoptosis, and prostaglandin synthesis as potential cellular mechanisms by 
which MEHP exposure, and possibly other environmental contaminants, may 




















Table 2.1. Oxidative stress and antioxidant response gene expression array results. 
HTR-8 cells were treated with DMSO (0.05% v/v; solvent control) or 180 !M MEHP for 4, 
8, or 24 h.  The Oxidative Stress and Antioxidant Response qRT-PCR Array was 
performed as described in the “Materials and Methods” section.  Results are shown for 
those genes with a significant change of approximately two-fold or more compared to 
solvent controls at 4, 8, or 24 h.  Statistically significant changes of two-fold or more are 













Figure 2.1.  MEHP-stimulated generation of reactive oxygen species (ROS).  MEHP 
treatment increased ROS generation in HTR-8 cells in a concentration-dependent 
manner as measured by the DCF assay.  HTR-8 cells were pre-loaded with H2DCF-DA 
for 1 h, then treated with DMSO, (0.05% v/v; solvent control) 10, 22.5, 45, 90, or 180 !M 
MEHP (n = 3-5 experiments) or 100 !M TBHP (n=2 experiments) for 1 h as described in 
the “Materials and Methods” section.  Bars represent means ± SE. *p < 0.05, compared 















































































Figure 2.2.  Effect of pretreatment with the antioxidant deferoxamine (DFO) on MEHP-
stimulated reactive oxygen species (ROS) generation.  HTR-8 cells were pre-loaded with 
H2DCF-DA for 1 h.  After removal of H2DCF-DA, cells were treated with 1 mM DFO for 1 
h, and then treated with DMSO (0.05% v/v; solvent control) or 180 !M MEHP as 
described in the “Materials and Methods” section (n=3 experiments).  The top panels 
show representative images of intracellular DCF fluorescence of A) solvent control, B) 
180 !M MEHP, and C) 180 !M MEHP + 1 mM DFO. The bottom panel shows 
corresponding Hoescht nuclear staining of D) solvent control, E) 180 !M MEHP, and F) 































































Figure 2.3A.  MEHP treatment effects on oxidation of the DNA base thymine.  HTR-8 
cells were treated with solvent control, 90 !M MEHP, 180 !M MEHP, or 50 !M TBHP for 
24 h.  Levels of oxidized thymine were measured from extracted genomic DNA and 
normalized to ppm total DNA base using mass spectrometry, as described in the 
“Materials and Methods” section.  All treatments were tested in experiment 1 (circle) and 
experiment 3 (triangle), and only solvent control and 90 !M MEHP were tested in 











Figure 2.3B.  Detection of oxidized thymine (as a mass-tagged deoxynucleotide) by 
MALDI-TOF-MS.  Peaks 1 and 2: oxidized thymine labeled with d0 and d4 mass tags, 
respectively.  Peak 3: mass tagged N2-ethyl dGMP spiked (25 fmol) into each MALD1 
spot as an internal standard.  A: peak 1 (1.7 ppm of oxidized thymine in DNA 
nucleobases) represents the DMSO sample and peak 2 (1.9 ppm) represents the 90 !M 
MEHP sample.  B: peak 1 (3.7 ppm) represents the180 !M MEHP sample and peak 2 














Figure 2.4. MEHP treatment effects on caspase 3/7 activity.  HTR-8 cells were treated 
with DMSO (0.05% v/v; solvent control), MEHP (22.5, 45, 90, or 180 !M), or 4 !M 
camptothecin (positive control) for 24 h, then caspase 3/7 activity was assessed as 
described in the “Materials and Methods” section (n = 3).  Bars represent means ± SE. 










































































Figure 2.5. Effects of MEHP on HTR-8 cell viability. Cells were treated with DMSO 
(0.05% v/v; solvent control), MEHP (22.5, 45, 90, or 180 !M), or 4 !M camptothecin 
(positive control) for 24 h or 48 h, then the cultures were assessed for cell viability using 
a commercial intracellular protease activity assay as described in the “Materials and 





























































































































































































































































































































































































































Figure 2.6.  qRT-PCR validation of gene array results (from Table 1), showing MEHP 
treatment effects on mRNA expression:  A) PTGS2; B) GLRX2; C)TXNRD1; D) 
DHCR24; E) SCARA3; F) PRNP; G) AOX1. Cells were treated for 24 h with medium 
alone (n=2), DMSO (0.05% v/v; solvent control), MEHP (90 !M or 180 !M), or TBHP (50 
!M) (n=3). qRT-PCR reactions were run as described in “Materials and Methods” 
























APPENDIX A  
MEHP effects on DCF fluorescence in cell-free buffer solutions 
 
Materials and Methods 
Measurement of MEHP-stimulated fluorescence with the H2DCF-DA assay. 
To assess the effects of MEHP on DCF fluorescence in cell-free buffer, 45, 90, 
and 180 !M MEHP solutions were prepared in either HBSS buffer or to RPMI 
medium with or without 10% fetal bovine serum (FBS).  H2DCF-DA reagent was 
mixed with each treatment or solvent control (0.05% DMSO) in HBSS or RPMI to 
a final concentration of 10 !M H2DCF-DA and 200 !l aliquots were added to a 
96-well plate in replicates of six.  Fluorescence readings were taken every 10 min 
for 1 h using a plate spectrofluorometer. 
 
Results 
MEHP effects on DCF fluorescence.  Exposure to MEHP for 1 h had no effect 
on DCF fluorescence in HBSS containing H2DCF-DA or RPMI medium 
containing H2DCF-DA in the absence of serum (Figure A.1, HBSS buffer, RPMI 
buffer).  However, 45, 90, and 180 !M MEHP concentrations significantly 
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increased DCF fluorescence when cell-free RPMI medium containing 10% serum 
and H2DCF-DA was used as the buffer  (Figure A.1; p<0.0001).   
Conclusion 
The results from the present study suggest that the DCF assay is appropriate for 
studying MEHP affects on ROS production when serum-free conditions are 












































Figure A.1.   MEHP effects on DCF fluorescence in HBSS and RPMI medium 
solutions.  MEHP effects on DCF fluorescence were determined after a1-h incubation in 
cell-free solutions containing 10 µM DCFH2-DA in HBSS or in RPMI medium with or 
without serum.  The bars represent the means of 3 independent experiments containing 
6 replicates each (n = 3).  There were significant increases in DCF fluorescence with 
MEHP treatments compared to solvent control when RPMI + serum was used as the 
buffer, but not when RPMI (without serum) or HBSS was used as the buffer.  Asterisks 
indicate statistically significant increases compared with not treated and solvent controls 
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MEHP stimulates release of prostaglandins but not inflammatory cytokines 
in human gestational cells and tissues  
 
Abstract 
Di-2-ethylhexyl phthalate (DEHP) is a ubiquitous environmental pollutant used in 
a wide variety of consumer polyvinyl chloride (PVC) products. Monoethylhexyl 
phthalate (MEHP), the active monoester metabolite of DEHP, increases release 
of inflammatory mediators, including prostaglandins and inflammatory cytokines 
in various tissues and cell types.   To investigate the effects of MEHP on 
inflammatory responses in the gestational compartment, we assessed MEHP-
stimulated prostaglandin and inflammatory cytokine responses in gestational 
membrane explants, placental macrophage Hofbauer cells, decidual macrophage 
cells, and human placental cells (HTR-8/SVneo). With IRB approval, term 
gestational tissues were obtained from healthy non-laboring term pregnancies 
delivered by cesarean section and first trimester decidual macrophages were 
obtained from women undergoing surgical abortion. Gestational cells and tissues 
were treated for 4, 8, or 24 h with MEHP concentrations ranging from 10-180 !M. 
PTGS2 mRNA expression of was measured in HTR-8 cells with qRT-PCR. 




significantly induced PTGS2 mRNA expression. Release of total prostaglandin, 
PGE2, PGF2", IL-6, IL-8, IL-1#, TNF-", IL-10, and TGF-# in cell culture medium 
was assessed using enzyme-linked immunosorbant assays (ELISA).  We found 
that 90 or 180 µM MEHP treatment significantly increased release of total 
prostaglandins in placental macrophage Hofbauer cells, decidual macrophages, 
and gestational membrane explants.  Treatment with 90 or 180 µM MEHP also 
increased PGF2", and PGE2 in human primary placental macrophage Hofbauer 
cells. MEHP treatment suppressed IL-10 levels in decidual macrophage cells but 
had no effects on inflammatory cytokine release in other in vitro models. These 
data suggest that MEHP may contribute to initiation of preterm labor through 














 Diethylhexyl phthalate (DEHP) is a ubiquitous environmental contaminant 
used widely as a plasticizer in polyvinyl chloride (PVC) consumer products.  
Because DEHP is not covalently bound to PVC, it is released into the 
environment where it collects in dust particles or in material contained in PVC 
plastic.  Consequently, human exposure to DEHP is widespread in the general 
population.  A recent study conducted by NHANES found measureable levels of 
monoethylhexyl phthalate (MEHP), the active metabolite of DEHP, in 98% of 
urine samples analyzed.  Because DEHP is rapidly converted to MEHP, which is 
excreted within hours of exposure, the NHANES findings suggest that exposure 
to DEHP is a widespread and daily occurrence.   
Exposure to DEHP is associated with adverse pregnancy outcomes in 
humans.  Specifically, phthalate exposure was associated with decreased 
gestation length in studies of women living in New York City and Italy (Latini, De 
Felice et al. 2003; Adibi, Hauser et al. 2009).  Likewise, phthalate urinary 
metabolites were associated with preterm birth in a Mexico City cohort.  
Conversely, a negative association between urinary DEHP metabolites and 
preterm birth was found in another New York City cohort (Wolff, Engel et al. 
2008).   
 Measureable levels of MEHP are found in human cord blood, placenta, 
and amniotic fluid, suggesting that tissues of the gestational compartment may 




al. 2009; Lin, Ku et al. 2011).  The placenta and extraplacental membranes of the 
gestational compartment are significant sources of signaling molecules, including 
inflammatory mediators, which are important for parturition.  Specifically, the 
placenta and extraplacental membranes produce and release pro-inflammatory 
cytokines and prostaglandins which together activate parturition events. Pro-
inflammatory cytokines stimulate synthesis of the bio-active prostaglandins PGE2 
and PGF2" in gestational tissues through induction of prostaglandin synthesis 
enzymes, including cyclooxygenase-2 (COX-2) (Hansen, Keelan et al. 1999).  
Bioactive prostaglandins PGE2 and PGF2" released from gestational tissues 
stimulate myometrial contractions (Olson 2003).   Pro-inflammatory cytokines 
tumor-necrosis factor alpha (TNF-") and interleukin-8 (IL-8) also promote cervical 
dilation and membrane rupture through activation of apoptosis and induction of 
matrix metalloproteinase (MMP) expression, respectively (Vadillo-Ortega and 
Estrada-Gutierrez 2005).  Furthermore, increased amniotic fluid levels of pro-
inflammatory cytokines IL-1!, IL-6, IL-8 and TNF-" and prostaglandins PGE2 
and PGF2" are evident in preterm labor (Romero, Manogue et al. 1989; Hillier, 
Witkin et al. 1993; Carroll, Abbas et al. 1995; Lee, Park et al. 2009; Yoneda, 
Shiozaki et al. 2011).  Hence, pro-inflammatory cytokine signaling and 
prostaglandin synthesis pathways work in concert to initiate myometrial 
contractions, cervical ripening, and membrane rupture, leading to initiation of 
human parturition and preterm labor.   
 Recent reports suggest that exposure to DEHP or its metabolite MEHP 




its oxidized metabolites are associated with urinary markers of inflammation 
(Ferguson, Loch-Caruso et al. 2011). In addition, MEHP treatment increases pro-
inflammatory cytokine release in primary neonatal neutrophils, rat alveolar 
macrophages, murine monocyte-macrophages, and human lung epithelial cells, 
suggesting activation of inflammatory responses with MEHP (Jepsen, Abildtrup 
et al. 2004; Rakkestad, Holme et al. 2010; Vetrano, Laskin et al. 2010).  
Similarly, MEHP treatment increases prostaglandin release from cultured bovine 
ovarian and endometrial cells, and increases COX-2 expression in 
spermatocytes and rat and human mast cells (Ledwith, Pauley et al. 1997; 
Onorato, Brown et al. 2008; Oh, Lim et al. 2010; Wang, Shang et al. 2010; Oh 
and Lim 2011).  Previous data collected from our laboratory show that MEHP 
treatment strongly induces expression of PTGS2, the gene for COX-2, in human 
placental cells.  The latter finding contrasts with a report that placental COX-2 
expression and prostaglandin production are decreased in pregnant rats exposed 
to DEHP compared to unexposed animals (Xu, Agrawal et al. 2008).   
 In the present study, we utilize a variety of in vitro model systems to 
examine the effects of MEHP treatment on prostaglandin synthesis and pro-
inflammatory cytokine release in cells and tissues of the gestational 
compartment.  Specifically, we assess MEHP-stimulated responses in first 
trimester placental cells (HTR-8/SVneo), primary decidual and placental 





Materials and Methods 
Reagents. We purchased dimethyl sulfoxide (DMSO), deferoxamine mesylate, 
tert-butyl hydroperoxide (TBHP), and camptothecin from Sigma-Aldrich (St. 
Louis, MO, USA); FBS and charcoal-stripped FBS from HyClone Laboratories 
(Waltham, MA); RPMI 1640, Dulbecco’s Modified Eagle Medium (DMEM), 
penicillin/streptomycin solution, and DPBS from Life Technologies-Invitrogen 
(Carlsbad, CA); recombinant IL-1# from R&D Systems (Minneapolis, MN); and 
MEHP from Accustandard (New Haven, CT). 
Human subjects.  This study was reviewed and approved by the Institutional 
Review Board (IRB) at the University of Michigan.  In compliance with the IRB, 
the investigators did not collect any personal identifiable information, the 
investigators had no direct interaction with the patient, and the tissues would 
otherwise have been discarded. 
Third trimester gestational tissue acquisition. Extraplacental gestational 
membranes and placental tissue were collected from women undergoing normal, 
medically indicated cesarean section delivery at the University of Michigan 
Women’s Hospital Birth Center between 37 and 39 weeks of gestation.  
Exclusion criteria included the following: preeclampsia, diabetes, multifetal 
pregnancy, collagen vascular disease, cervical cerclage, immune-compromised 
conditions, bacterial vaginosis or clinical chorioamnionitis (as noted in the chart 
or suspected by attending physician), prescription of antibiotics in the past two 




smoking, third trimester bleeding, major maternal medical conditions (e.g., 
chronic renal disease, sarcoidosis, hepatitis, HIV), or any condition requiring the 
tissues to undergo pathological examination.  
 Immediately following delivery, extraplacental membranes were excised 
from the placental disk, maintaining a 3-mm margin from the chorionic plate, and 
submerged in warm isotonic Dulbecco’s phosphate buffered saline (DPBS).  For 
placental macrophage isolations, a 5 g sample of tissue was excised from the 
chorionic villous stalk of the placenta and placed in warm DPBS.  Samples were 
then transported to the laboratory for further processing. 
First trimester decidual tissue acquisition. First trimester decidual tissues 
were collected from women age 18-44 undergoing surgical abortion at Planned 
Parenthood of Mid-Michigan. Exclusion criteria included subjects receiving 
immunosuppressive medications, subjects with acute reproductive tract infection, 
and subjects with chronic medical conditions of the skin, heart, lung, liver, 
gastrointestinal tract, endocrine, reproductive, hematological, neurological, 
musculoskeletal, or immune systems. Tissues requiring pathological 
examination, as determined by the physician, were excluded from this study.  
Immediately following the abortion procedure, decidual tissue was separated 
from the gestational sac and fetal tissues by the physician and then placed in 
isotonic DPBS by the researchers.  
Placental and decidual macrophage isolation.  Placental and decidual 




al. 2010).  Before mincing, placental tissues were washed 3 times with DPBS to 
remove blood.  The purity of decidual and placental isolates was between 92-
94%, determined with flow cytometry as cells positive for CD14+.Cells were 
seeded at a density of 200,000-400,000 cells per well in a polystyrene, 24-well 
culture plate in RPMI with antibiotics (100 U/mL penicillin and 100 !g/mL 
streptomycin) and 10% charcoal dextran FBS, and then incubated for 24 h in a 
humidified atmosphere at 37°C and 5% CO2. 
Extraplacental gestational membrane tissue culture and treatment. Under 
aseptic conditions, tissues were washed 3 times in warm DPBS to remove blood 
and 12-mm punches of full-thickness tissue were made using a biopsy punch. 
Punches were then placed, one punch per well, in a 12-well polystyrene culture 
plate containing 1 mL per well of warm DMEM supplemented with 100 units/ml 
penicillin and 100 !g/ml streptomycin.  Following 4 h of culture in a humidified 
atmosphere at 37°C and 5% CO2, medium was removed and replaced with fresh 
medium, and the punches were incubated for an additional 24 h.  The medium 
was replaced and tissue was allowed to incubate for 1 h before treatment.  
Tissue punches were treated in triplicate with medium alone, 0.05% dimethyl 
sulfoxide (DMSO; solvent control), or 22.5, 45, 90, or 180 !M MEHP, or 100 
ng/mL LPS for 24 h.   
Placental and decidual macrophage culture and treatment.   Primary 
macrophage cells were treated with medium alone, 0.05% DMSO (solvent 
control), 90 !M MEHP or 180 !M MEHP in triplicate in RPMI 1640 medium with 




100 U/mL penicillin and 100 !g/mL streptomycin for 8 or 24 h in a humidified 
atmosphere at 37°C and 5% CO2.  
HTR-8/SVneo cell culture and treatment.  The HTR-8/SVneo (HTR-8) cells 
were a gift from Dr. Charles Graham (Queens University, Ontario, Canada).  The 
HTR-8 cells were isolated from first trimester human placenta and immortalized 
with SV40 antigen (Graham, Hawley et al. 1993).  Similar to their primary 
counterparts, HTR-8 cells express human chorionic gonadropin, stain positive for 
the epithelial marker cytokeratin-7, and retain migratory capabilities in culture 
(Graham, Hawley et al. 1993).  Cells were cultured in RPMI 1640 medium with L-
glutamine without phenol red, supplemented with 10% fetal bovine serum and 
100 U/mL penicillin and 100 !g/mL streptomycin at 37°C in a 5% CO2 humidified 
atmosphere.  Cells were grown to approximately 70-80% confluence before 
treatment. For cytokine and prostaglandin measurements, cells were seeded at 
100,000 cells per well in a 24-well culture plate. Following a 24 h incubation, cells 
were treated with 0.05% DMSO (solvent control), 10, 22.5, 45, 90 or 180 !M 
MEHP, or 100 ng/mL LPS (positive control) for 24 h.  The 24-h time point was 
selected based on a preliminary time-course experiment in which we determined 
that 24 h gave optimal cytokine responses.   For qRT-PCR, cells were seeded 
400,000 cells per well in a 6-well culture plate. Following a 24-h incubation, cells 
were treated with medium alone, 0.05% DMSO (solvent control), 90 or 180 !M 
MEHP for 4, 8, or 24 h.   
Prostaglandin quantification.  Because MEHP increased expression of PTGS2 




concentrations in HTR-8 cells, primary placental and decidual macrophages, and 
gestational membrane punches.   Total prostaglandin release was measured in 
gestational tissue and primary macrophage cell medium using the Prostaglandin 
Screening EIA kit (Cayman Chemical, Ann Arbor, MI).  Prostaglandin E2 (PGE2) 
concentrations in primary macrophage and HTR-8 cell medium and 
prostaglandin F2" (PGF2") concentrations in primary macrophage medium were 
quantified with enzyme immunoassay following the manufacturer’s 
recommended protocol (EIA; Cayman Chemical, Ann Arbor, MI, USA).   
Cytokine quantification. Interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-1# 
(IL-1#), tumor necrosis factor-" (TNF-"), transforming growth factor beta (TGF-#) 
and interleukin-10 (IL-10) concentrations were quantified in cell and tissue 
medium by enzyme-linked immunosorbent assay (ELISA) following the 
manufacturer’s recommended protocol (Duosets, R&D systems, Minneapolis, 
MN) in the Immunology Core Facility at the University of Michigan Cancer 
Center. 
qRT-PCR for PTGS2 mRNA expression.   After 4, 8, or 24 h of exposure, RNA 
was extracted from HTR-8 cells using the RNeasy Plus Mini Kit (Qiagen), and 
cDNA was synthesized from 1 !g of total RNA using the RT2 First Strand Kit 
(SABiosciences) following the manufacturers' recommended protocols.  Using 
the SABiosciences RT2 First Strand Kit, cDNA was made from 1 !g of mRNA.  
PCR reactions were run with the SYBR Green Mastermix (SABiosciences), with 
5 !L of template. RT- PCR reactions were run on the Bio-Rad CFX96 Real Time 





PTGS2 mRNA expression, prostaglandin, and cytokine response in HTR-8 
cells.  Treatment of HTR-8 cells with 180 !M MEHP for 4, 8, or 24 h increased 
PTGS2 expression 5.3 (±0.6), 8.4 (±2.0), and 6.7 (±0.7) fold, respectively (Figure 
3.1). Treatment with 90 !M MEHP for 4 or 8 h resulted in fold increases in 
PTGS2 expression of 2.2 (±0.2) and 3.3 (±0.7), respectively.  PGE2 
concentrations in the medium were below the limit of detection of the assay for all 
treatments assayed (data not shown).  Treatment with MEHP had no effect on IL-
6 or IL-8 release whereas 100 ng/mL LPS, included as a positive control, 
stimulated both IL-6 and IL-8 release (Figure 3.2).  IL-10 and TNF-" 
concentrations were near or below the limit of detection for all treatments 
assayed (data not shown).   
Prostaglandin release in placental macrophage cultures.  Treatment of 
primary placental macrophages with 90 or 180 µM MEHP for 8 or 24 h increased 
total prostaglandin release (Figure 3.3), PGF2! release (Figure 3.4), and PGE2 
release (Figure 3.5) into the culture medium.  Treatment of primary placental 
macrophages from subject 1, 2, or 3 with MEHP significantly increased 
prostaglandin release by 34.5, 11.9, and 4.5 fold, respectively; PGF2! release by 
3.2, 1.3, and 1.4 fold, respectively; and PGE2 release by 2.2 and 1.9 fold, 
respectively.  Solvent control cultures (0.05% DMSO v/v) showed no significant 
changes of total prostaglandin, PGF2!, or PGE2 release compared to cultures 




Prostaglandin and cytokine release in decidual macrophage cultures.  
Consistent with the response in placental macrophages, treatment of primary 
decidual macrophages with 90 !M MEHP for 24 h significantly increased total 
prostaglandins release by 1.7 fold (Figure 3.6).  Treatment with MEHP for 8 h 
significantly decreased release of IL-10 into the culture medium (Figure 3.7A) but 
had no effect on IL-6, IL-8, TNF-!, or TGF-! release after 8 or 24 h of treatment 
(Figure 3.7 B, C, D, and E, respectively).  Treatment with10 ng/mL IL-1! (positive 
control) for 8 or 24 h significantly increased release of all cytokines measured 
(Figure 3.7).  
 Prostaglandin and cytokine release in gestational membrane explant 
cultures.  Treatment of gestational membrane punches with 180 !M MEHP for 
24 h significantly increased release of total prostaglandins by 2.5 fold (Figure 3.8 
A).   However, within-tissue variability was high for most of the subjects (Figure 
3.8. B, C, D, and E).  MEHP had no significant effects on release of any of the 
cytokines measured (Figure 3.9).  However, treatment of gestational membrane 
punches for 24 h with 100 ng/mL LPS, included as a positive control, stimulated 
IL-6, IL-8, TNF-!, and IL-10 (Figure 3.9 A, B, C, and D, respectively).  IL-6 and 
IL-8 release in gestational tissues was highly variable both between subjects and 
within subjects (within subject data not shown).The solvent control (0.05% 
DMSO) showed no effects on prostaglandin release compared to medium alone.  
In earlier experiments, we found that 0.05% DMSO showed no effects on IL-6, 






 The objective of the current study was to investigate inflammatory 
responses in various gestational tissues and cells following MEHP treatment in 
vitro.  Our results demonstrate that MEHP treatment significantly increased 
release of total prostaglandins, PGF2", and PGE2 in human primary placental 
macrophage Hofbauer cells, and induced PTGS2 mRNA expression in the HTR-
8 human trophoblast cell line.   Furthermore, our data suggest that MEHP 
suppresses levels of the anti-inflammatory cytokine IL-10 in decidual 
macrophage cells, though these results require replication using cells from 
additional subjects. These data suggest that MEHP may contribute to initiation of 
preterm labor through increased bioactive prostaglandin synthesis in the 
gestational compartment. 
Bioactive prostaglandin synthesis is a critical event for the initiation of 
human parturition, mediating such events as myometrial contractions and 
cervical ripening. Inhibition of prostaglandin synthesis with COX-2 inhibitors 
delays pregnancy and prevents preterm labor in rodents, and in vitro exposure to 
bioactive prostaglandins stimulates myometrial contractions and labor (Wikland, 
Lindblom et al. 1984; Lee, Kim et al. 2003; Fischer, Hutchinson et al. 2008). In 
humans, increases in the bioactive prostaglandins PGE2 and PGF2 in tissues 
and fluids of the gestational compartment precede and correspond with preterm 
and term labor (Mazor, Wiznitzer et al. 1990; Lee, Romero et al. 2008). Though 
the placenta is considered the primary producer of prostaglandins in the 




prostaglandin release in placental macrophage Hofbauer cells, which reside in 
the lumen of the chorionic villi of the placenta (Wetzka, Clark et al. 1997).  Novel 
to the present study is the finding that MEHP significantly increases release of 
bioactive prostaglandins PGE2 and PGF2" and total prostaglandins in human 
primary term placental macrophage Hofbauer cells at physiologically relevant 
concentrations.  Also novel is our finding that MEHP stimulated release of total 
prostaglandins in term gestational membrane explants and first trimester primary 
decidual macrophage cells.  These results are corroborated by the findings from 
a previous study where MEHP treatment increased release of PGF2" in bovine 
ovarian and endometrial cells (Wang, Shang et al. 2010).  However, our results 
are inconsistent with the findings from a previous study where DEHP exposure 
(750 – 1500 mg/kg/day oral gavage) resulted in decreases in total placental 
prostaglandins in pregnant rats (Xu, Agrawal et al. 2008).  The differences 
between the latter study and the present study prostaglandin responses to MEHP 
could be explained by species differences in prostaglandin synthesis pathway 
responses or differences between in vivo and in vitro systems. Furthermore, the 
doses of DEHP used in the latter study were at least four orders of magnitude 
greater than the 95th percentile of estimated adult human intake of 21 !g/kg/day 
(Koch, Preuss et al. 2006).   
Interestingly, the concentration and magnitude of increase of PGE2 and 
PGF2" release observed with MEHP treatment in placental macrophages did not 
fully explain the increase in total prostaglandin levels observed with MEHP 




recognizes arachadonic acid-derived COX-dependent thromboxane and 
prostacyclin as well as prostaglandins synthesized by COX conversion of 
eicosapentaenoic acid and dihomo-gamma-linolenic acid.  Additionally, the 
prostaglandin screening EIA recognizes COX-independent isoprostanes, 8-iso 
prostaglandin F2" (8-iso PGF2") and 8-iso prostaglandin E2 (8-iso PGE2), that 
are synthesized from reactive oxygen species (ROS) oxidation of arachadonic 
acid.  Based on our finding that MEHP strongly induces PTGS2 expression in 
HTR-8 cells, future experiments in placental macrophages could include 
measurements of PTGS2 mRNA expression, COX-2 protein expression, and 
release of COX-2 dependent thromboxane and prostacyclin.  In addition, based 
on our findings from Chapter II that MEHP treatment induces oxidative stress 
responses, we intend to measure release of isoprostanes following MEHP 
treatment of placental macrophages.  Increased urinary isoprostanes early in 
gestation are predictive of preterm labor and preeclampsia; however, the function 
of isoprostanes in the parturition processes is not known (Peter Stein, Scholl et 
al. 2008).  Previous studies demonstrate, though, that isoprostanes are bioactive 
and interact with excitatory receptors, similar to PGE2 and PGF2 (Hoffman, 
Moore et al. 1997; Friel, Sexton et al. 2006).  Similarly, we plan to further 
investigate PGE2, PGF2", and isoprostane release in the gestational membrane 
explant model to identify specific prostaglandin increases that may explain the 
observed increase in total prostaglandins. 
Pro-inflammatory cytokines are important mediators of both preterm and 




labor as an inflammatory event, with pro-inflammatory cytokine induction.  Pro-
inflammatory cytokines mediate prostaglandin synthesis and release, matrix 
metalloproteinase activation and expression, and recruitment of inflammatory 
cells, leading to labor events including membrane rupture, cervical ripening, and 
uterine contractions (Kamel 2010).  In our gestational tissue and cell models, 
MEHP stimulated prostaglandin synthesis without effects on pro-inflammatory 
cytokine release.  The latter finding suggests that MEHP may work through a 
non-traditional, pro-inflammatory cytokine independent pathway to initiate 
prostaglandin synthesis.  Previous studies from other laboratories demonstrate 
that antioxidant treatment prevents COX-2 induction and PGE2 synthesis and 
release (Mögel, Baumann et al. 2011; Temma-Asano, Tskitishvili et al. 2011).  In 
addition, results from Chapter II of this thesis demonstrate that MEHP induces 
ROS generation in gestational cells.  Based on the latter two findings, we 
propose that MEHP may stimulate prostaglandin synthesis through ROS 
generation.  Alternatively, PPARs, for which MEHP is a ligand, can initiate 
prostaglandin synthesis by interacting with the PTGS2 promoter to induce 
PTGS2 gene expression (Kusu, Oishi et al. 2008).  However, the effects of 
PPARs on PTGS2 gene expression are cell-type specific and in some cases 
PPAR activation can result in suppression of PTGS2 expression (Kang, Mbonye 
et al. 2007; Scoditti, Massaro et al. 2010).  Further research, beyond the scope of 
the present study, is needed to elucidate these early events in the up regulation 




Although we observed no changes in pro-inflammatory cytokine release 
with MEHP in any of our in vitro models, we did observe a significant suppression 
of IL-10 release in first-trimester decidual macrophages with MEHP treatment.  
This novel finding suggests that exposure to MEHP during the first trimester of 
pregnancy may have effects on the ability of macrophages to maintain sufficient 
IL-10 levels necessary for protection from innate immune activation and fetal 
tissue rejection (Nagamatsu and Schust 2010).  IL-10 deficiency or 
polymorphism is associated with preeclampsia, miscarriage, and preterm birth, 
and DEHP exposure has recently been associated with early pregnancy loss and 
preterm birth in humans (Hennessy, Pilmore et al. 1999; Kaur 2011; Ruiz, Jallo et 
al. 2012).  Due to difficulty in obtaining first-trimester tissues, we only have data 
from one subject demonstrating MEHP suppression of IL-10. Further 
experiments in isolates from additional subjects are necessary to determine 
whether or not these effects are reproducible.  Furthermore, because IL-10 is 
important for suppression of innate immune responses and women with IL-10 
polymorphisms are at greater risk of preterm birth, future studies could 
investigate the effects of MEHP treatment on term decidual macrophage IL-10 
secretion.    
The findings from this study suggest a possible mechanism whereby 
MEHP exposure during pregnancy could stimulate myometrial contractions and 
ultimately preterm labor through induction of bio-active prostaglandin synthesis.  




PGE2 and PGF2" urinary metabolite levels, MEHP exposure, and preterm birth 







































































Figure 3.1.  MEHP treatment effects on mRNA expression of PTGS2 in HTR-8 cells.  
Cells were treated for 4, 8, or 24 h with medium alone, DMSO (0.05% v/v; solvent 
control), 90 !M MEHP or 180 !M MEHP, and then qRT-PCR reactions were run as 
described in the “Materials and Methods” section.  Solvent control cultures showed no 
significant changes of PTGS2 expression compared to cultures exposed to medium 
















































































































































Figure 3.2.  MEHP treatment effects on cytokine release from HTR-8 cells into culture 
medium.  Cells were treated for 24 h with medium alone, DMSO (0.05% v/v; solvent 
control), or 10, 22.5, 45, 90 or 180 !M MEHP.  A) IL-6 release in HTR-8 cells.  B) IL-8 
release in HTR-8 cells. IL-6 and IL-8 ELISAs were performed as described in “Materials 
and Methods” section.  Solvent control cultures (0.05% DMSO v/v) showed no significant 
changes of cytokine release compared to cultures exposed to medium alone (data not 
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Figure 3.3. MEHP treatment effects on total prostaglandin release from primary 
placental macrophages into cell culture medium. Data are shown from three subjects.  
Cells were treated for 8 h (Subject 2) or 24 h (Subjects 1 and 3) with medium alone, 
DMSO (0.05% v/v; solvent control), 90 !M MEHP or 180 !M MEHP.  The prostaglandin 
screening EIA was performed as described in the “Materials and Methods”.  Data points 
represent individual wells for each subject: open circles are solvent control values and 
filled circle are from cultures exposure to MEHP (n = 3 wells per treatment). Horizontal 
lines indicate mean values for each treatment within each subject.  *p<0.05, compared 
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Figure 3.4.  MEHP treatment effects on PGF2" release from primary placental 
macrophages into cell culture medium. Data are shown from three subjects.  Cells were 
treated for 8 h (Subject 2) or 24 h (Subject 1 and 3) with medium alone, DMSO (0.05% 
v/v; solvent control), 90 !M MEHP or 180 !M MEHP.  The PGF2" EIA was performed as 
described in the “Materials and Methods” section.  Data points represent individual wells 
for each subject: open circles are solvent control values and filled circle are from cultures 
exposure to MEHP (n = 3 wells per treatment). Horizontal lines indicate mean values for 





































Figure 3.5.  MEHP treatment effects on PGE2 release from primary placental 
macrophages into cell culture medium.  Data are shown from two subjects.  Cells were 
treated for 8 h (Subject 2) or 24 h (Subject 1) with medium alone, DMSO (0.05% v/v; 
solvent control), 90 or 180 !M MEHP.  The PGE2 EIA was performed as described in 
the “Materials and Methods” section.  Data points represent individual wells for each 
subject: open circles are solvent control values and filled circle are from cultures 
exposure to MEHP (n = 3 wells per treatment). Horizontal lines indicate mean values for 






















































Figure 3.6.  MEHP treatment effects on total prostaglandin release from primary 
decidual macrophage cell medium.  Cells isolated from one subject were treated for 24 h 
with medium alone, DMSO (0.05% v/v; solvent control), or 90 !M MEHP.  The 
prostaglandin screening EIA was performed as described in “Materials and Methods” 
section (means ± SE, n = 3 wells per treatment).  Solvent control cultures (0.05% DMSO 
v/v) showed no significant changes of total prostaglandin release compared to medium 




























































































































Figure 3.7. MEHP treatment effects on cytokine release from decidual macrophages 
into cell culture medium: A) IL-10; B) IL-6; C) IL-8; D) TNF-"; and E) TGF-#. Cells 
were treated for 8 h or 24 h with medium alone, DMSO (0.05% v/v; solvent control), 
90 !M MEHP or IL-1# (positive control), and then cytokine concentrations in the 
culture medium were determined by ELISA as described in the “Materials and 
Methods” section.  Data shown are from macrophages collected from one subject.  






































































































































































































































































Figure 3.8.  MEHP treatment effects on total prostaglandin release in gestational 
membrane explant medium. Figure 4A shows the subject averages for DMSO 
(0.05% v/v; solvent control), and 180 !M MEHP.  Figures B- E show the individual 
replicate punch measurements for each subject (n=3 punches per subject).  Cells 
were treated for 24 h with medium alone, DMSO (0.05% v/v; solvent control), 180 
!M MEHP, or 100 ng/mL LPS.  The prostaglandin screening EIA was performed as 
described in the “Materials and Methods” section. (means ± SE, n = 4 subjects.  
Figures B-E show data points representing 3 individual wells for each subject (n = 3 
wells per treatment). Horizontal lines indicate mean values for each treatment within 
each subject.  Solvent control cultures (0.05% DMSO v/v) showed no significant 
changes of prostaglandin release compared to medium alone (n=2 subjects).  









































































































































































































































































































































































































Figure 3.9.  MEHP treatment effects on cytokine release from gestational membrane 
explants into cell culture medium: A) IL-6; B) IL-8; C) TNF-"; D); E) IL-10; and F)TGF-#. 
Punches were treated for 24 h with medium alone, DMSO (0.05% v/v; solvent control), 
22.5, 45, 90 or 180 !M MEHP, or 100 ng/mL LPS and.  Cytokine ELISAs were 
performed as described in the “Materials and Methods” section.  Each black circle 
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The present study is the first to identify cellular mechanisms by which 
MEHP may contribute to adverse pregnancy outcomes in human in vitro 
gestational cell and tissue models. Our results demonstrate that MEHP induces 
oxidative stress responses ranging from generation of hydroxyl radical, increased 
DNA damage, and modification of redox sensitive gene expression to activation 
of apoptotic proteases caspase 3/7. In addition, MEHP treatment stimulated 
prostaglandin synthesis, evidenced by increases in total prostaglandin release 
from immortalized human placental cells, decidual macrophages, placental 
macrophage Hofbauer cells, and gestational membrane explants. Moreover, 
MEHP increased release from placental macrophage Hofbauer cells of PGE2 
and PGF2!, bioactive prostaglandins that promote uterine contractions. 
Though the importance of prostaglandin synthesis in the initiation of 
parturition is clear, the role of oxidative stress responses in labor is not well 
understood.  Association studies suggest a link between oxidative stress 
endpoints and preterm birth; however, few studies examine generation of ROS 
as a mediator of parturition pathways (Al-Gubory, Fowler et al. 2010; Pathak, 
Suke et al. 2010; Menon, Fortunato et al. 2011; Clerici, Slavescu et al. 2012).  
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Some insight can be gained from N-acetyl cysteine antioxidant pretreatment 
studies demonstrating that ROS species generation is necessary for LPS-
induced preterm birth in mice and necessary for LPS-stimulated pro-inflammatory 
cytokine and prostaglandin release in gestational membrane explant cultures  
(Buhimschi, Buhimschi et al. 2003; Lappas, Permezel et al. 2003) .  Similarly, 
oxidative insult can induce apoptosis in placental and gestational membrane 
chorionic trophoblast cells (Moll, Jones et al. 2007; Rogers, Ouellet et al. 2008; 
Yuan, Ohyama et al. 2008). Results from our laboratory suggest that treatment 
with the prototypical chemical oxidant, TBHP stimulates parturition-related 
pathways, including prostaglandin synthesis, apoptosis, and signal transduction 
in human placental cells, suggesting that ROS signaling may be important for 
initiation of these events (Cassandra Korte, personal communication).  
Furthermore, anti-oxidant pretreatment prevents MEHP-induced apoptosis in 
male germ cells and TK lymphoblasts and prevents DEHP-induced antral follicle 
injury in mice, suggesting that toxicologic and pathologic outcomes of MEHP 
treatment can be mediated through ROS generation (Rosado-Berrios, Velez et 
al. 2011; Wang, Craig et al. 2012). 
Although not directly tested, the data in this dissertation are consistent 
with the following proposed model: that ROS generation stimulates prostaglandin 
synthesis, apoptosis, redox-sensitive gene expression and oxidative DNA 
damage in gestational tissues and cells, promoting the events of parturition 
(Figure 4.1).  PTGS2 gene expression is controlled by a number of transcription 
factors that can be activated by ROS species , including AP-1, SP-1, and NF-!B 
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(Kang, Mbonye et al. 2007).  These transcription factors can be activated by 
ROS through oxidation of redox-sensitive residues, such as cysteines existing 
within the protein itself, or through activation or modification by ROS of inhibitory 
proteins or upstream regulatory factors.   For example, intracellular ROS 
generation resulting from an oxidative stimulus can lead to dissociation and 
degradation of the NF-!B inhibitory protein I!B, resulting in migration of the NF-
!B subunit to the nucleus where it can initiate transcription (Allen and Tresini 
2000).  Similarly, ROS can inactivate phosphatases through direct oxidation of 
cysteine residues, resulting in increased kinase activity (Ma 2010); this signal can 
then be propagated to downstream kinase-dependent transcription factors, such 
as AP-1, NF-!B, and SP-1 (Allen and Tresini 2000; Ma 2010).  Additionally, 
executioner caspases, including caspase 3/7 can be directly activated by ROS 
through redox sensitive cysteines, or indirectly through p53 activation following 
oxidative damage to DNA (Circu and Aw 2010).   
 Our finding that MEHP treatment increases ROS generation in human 
placental cells is corroborated by results from other studies demonstrating ROS 
generation with MEHP in cells and tissues from other organ systems.  Despite 
the evidence linking MEHP exposure to increases in ROS generation, the 
mechanism underlying this occurrence is unknown.  Because MEHP can activate 
the nuclear receptor PPAR through direct binding, some authors postulate that 
MEHP may increase hydrogen peroxide generation through peroxisome 
proliferation.  This latter hypothesis is challenged, however, by studies 
demonstrating that MEHP-induced ROS generation is independent of PPAR"  
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(Rusyn, Kadiiska et al. 2001; Kamijo, Hora et al. 2007).  MEHP can also affect 
mitochondrial permeability, resulting in leakage of superoxide anion into the 
cytoplasm; however, it is unknown how MEHP affects mitochondrial permeability 
(Rosado-Berrios, Vélez et al. 2011).  Additionally, cytochrome P450 metabolism 
of MEHP to its oxidized metabolites may generate superoxide and thereby 
represent another possible mechanism of MEHP-induced ROS generation. 
Lastly, because some phthalates can act as iron chelators, some phthalates, 
including MEHP, may increase Fenton-dependent hydroxyl radical production 
through facilitation of iron transport into and within the cell (Chang and Zylstra 
1999).  Further work is need to elucidate the mechanism of MEHP induced ROS 
generation. 
 With the exception of total prostaglandin release and cytokine analysis in 
whole tissue explants, the majority of this work was performed in cell culture 
models.  The benefits of using cell culture models to study mechanisms of 
toxicity include ease of studying cell signaling mechanisms and measurement of 
ROS generation using cell-permeable, ROS-sensitive probes.  Furthermore, as 
evidenced by the work in this proposal, primary cell isolates exhibit less within-
subject variability in cytokine and prostaglandin responses as compared to 
gestational tissue explants.  We recognize, however, that important cell-cell and 
tissue-tissue interactions may be missed when using cell culture models.  
Therefore, future studies should include measurements of oxidative stress 
responses with MEHP in whole tissue and in vivo exposure scenarios. Recent 
development of a photostable, tissue-permeable hydrocyanine ROS dye provides 
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possibilities for studying ROS generation both in vivo and in whole tissue culture 
(Kim, Choi et al. 2011; Selvam, Kundu et al. 2011).  Furthermore, measurement 
of oxidative stress endpoints, including oxidized thymine measurements, 
caspase activity, and redox-sensitive gene expression can be applied to in vivo 
and whole tissue explant MEHP exposure scenarios.   
The mechanisms of MEHP-induced toxicity identified in the present study 
can inform future molecular epidemiology studies to further strengthen the link 
between MEHP exposure and adverse pregnancy outcomes, including preterm 
birth. To strengthen the hypothesis that MEHP targets the gestational 
compartment, further studies could correlate urinary or gestational tissue MEHP 
concentrations with measurements of oxidative stress markers, including 8-
hydroxy-2-deoxyguanosine (8-OHdG), malondialdehyde (MDA) and antioxidant 
protein expression, in addition to prostaglandin pathway factors including COX-2 
protein and PTGS2 mRNA.  Furthermore, circulating or urinary measures of 8-
OHdG, MDA, antioxidants, and prostaglandin metabolites can also be correlated 
with MEHP exposure and preterm birth (Minuz, Covi et al. 1988).  
In the current study, we were interested in effects of MEHP on preterm 
birth related responses relevant to the third trimester of gestation. Due to the 
limited availability of immortalized human gestational cells with normal 
chromosome number and phenotypes similar to primary cells or term primary 
macrophage cells, we chose to work with the HTR-8 cells and primary decidual 
macrophages, which originate from first trimester placenta, to study mechanisms 
relevant to parturition.  We recognize, however, that the mechanisms studied in 
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this dissertation may be relevant to first-trimester adverse pregnancy outcomes 
as well, including preeclampsia and early pregnancy loss.  As described in 
Chapter I, preeclampsia is linked to oxidative stress and apoptosis.  In addition, 
PGE2 promotes migration of first trimester trophoblast cells in culture, a process 
important for proper vascularization of the placenta (Nicola, Lala et al. 2008).  
Furthermore, as described in Chapter II, IL-10 release by decidual macrophages 
helps to prevent maternal tissue rejection of the fetal allograft, a pathology linked 
to early pregnancy loss (Nagamatsu and Schust 2010).  Future studies could 
elaborate on apoptosis, oxidative stress, and prostaglandins as mechanisms of 
MEHP-induced, first-trimester adverse pregnancy outcomes. 
The concentrations of MEHP tested in the present study are comparable 
to concentrations of MEHP tested for ROS generation in previous studies in other 
cells types.  Furthermore, the concentrations at which MEHP induced ROS 
production are comparable to the higher range of MEHP concentrations found in 
the gestational compartment.  Specifically, the concentrations used in the current 
study were within an order of magnitude of reported human umbilical cord blood 
concentrations that range from 0.01 µM to 35 µM (Latini, De Felice et al. 2003; 
Lin, Zheng et al. 2008; Lin, Wang et al. 2011).  Concentrations of MEHP in 
placental tissue range from 0 to 14.96 ug/kg (n=5 subjects) (Mose, Mortensen et 
al. 2007).  Further studies with larger samples sizes are needed to more 
accurately assess placental exposure.   
In summary, the findings from this study suggest a possible mechanism 
whereby MEHP exposure during pregnancy could contribute to preterm birth 
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through induction of bio-active prostaglandin synthesis, apoptosis, and oxidative 
stress.  Based on these findings, future studies investigating the associations 
between the latter endpoints, MEHP exposure, and preterm birth in human 
populations are warranted.   Furthermore, prostaglandin synthesis, oxidative 
stress and apoptosis may represent mechanisms by which other environmental 
pollutants could contribute to preterm birth.  Therefore, this work warrants future 
studies investigating the effects of other environmental pollutants on 
prostaglandin synthesis, oxidative stress, and apoptosis in human gestational 









Figure 4.1.  Conceptual model of MEHP effects in gestational tissues and cells. Reactive 
oxygen species (ROS) generation stimulates prostaglandin synthesis, apoptosis, redox-sensitive 
gene expression and oxidative DNA damage in gestational tissues and cells, promoting the 
events of parturition.  Endpoints that were directly tested in this dissertation are highlighted in 
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